OHSU Secures NIH Funding for Inherited Kidney Disease Gene Therapy Research

Oregon Health & Science University (OHSU) has received over $7.5 million in new funding from the National Institutes of Health (NIH) to advance gene therapies for inherited kidney diseases like Alport syndrome and cystinuria. These conditions currently necessitate lifelong medical complications, dialysis, or organ transplantation. The multi-year grants will support developing adeno-associated virus (AAV) gene therapies, aiming to overcome technical hurdles in delivering therapeutic genes to specific kidney cells, potentially offering curative treatments where none currently exist.